Advanced glycation end-products in anterior chamber aqueous of cataractous patients

Journal of Cataract and Refractive Surgery

Volumn 29, Issue 2, 2003, Pages 329-335

  Franke, Sybille ^a   Stein, Friederike ^a   Dawczynski, Jens ^a   Blum, Marcus ^a   Kubetschka, Ulrich ^a   Stein, Günter ^a   Strobel, Jürgen ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALBUMIN; IMIDAZOLE DERIVATIVE; IMIDAZOLONE; PENTOSIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACTOGENESIS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LASER FLARE CELL METER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0037328731     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(02)01524-9     Document Type: Article

References (18)

1. Crabbe MJC. Cataract as a conformational disease - the Maillard reaction, alpha-crystallin and chemotherapy. Cell Mol Biol 1998; 44:1047-1050
2. Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol 2001; 85:746-753
3. Nagaraj RH, Shamsi FA, Huber B, Pischetsrieder M. Immunochemical detection of oxalate monoalkylamide, an ascorbate-derived Maillard reaction product in the human lens. FEBS Lett 1999; 453:327-330
4. Nagaraj RH, Sady C. The presence of a glucose-derived Maillard reaction product in the human lens. FEBBS Lett 1996; 382:234-238
5. Boscia F, Grattagliano I, Vendemiale G, et al. Protein oxidation and lens opacity in humans. Invest Ophthalmol Vis Sci 2000; 41:2461-2465
6. Altomare E, Grattagliano I, Vendemiale G, et al. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur J Clin Invest 1997; 27:141-147
7. ε-(carboxymethyl)lysine in lens proteins. Biochemistry 1989; 28:9464-9468
8. ε-(carboxymethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997; 324:565-570
9. Zarina S, Zhao HR, Abraham EC. Advanced glycation end products in human senile and diabetic cataractous lenses. Mol Cell Biochem 2000; 210:29-34
10. Hashimoto H, Arai K, Yoshida S, et al. Pentosidine and autofluorescence in lenses of diabetic patients. Jpn J Ophthalmol 1997; 41:274-277
11. Franke S, Dawczynski J, Blum M, et al. Levels of advanced glycation end-products (AGEs) in human cataractous lenses [abstract]. Exp Clin Endocrinol Diabetes 2000; 108:A2
12. Sawa M, Tsurimaki Y, Tsuru T, Shimizu H. New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol 1988; 32:132-142
13. Miyata T, Ueda Y, Shinzato T, et al. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 1996; 7:1198-1206
14. Oshika T, Kato S, Sawa M, Masuda K. Aqueous flare intensity and age. Jpn J Ophthalmol 1989; 33:237-242
15. Blum M, Müller UA, Höche A, et al. Flaremessung und Albuminurie bei Typ-I-Diabetikern. Klin Monatsbl Augenheilkd 1998; 212:80-83
16. Kruger H, Busch T. Korrelation zwischen Lasertyndallometrie und Eiweisskonzentration in derAugenvorderkammer. Ophthalmologe 1995; 92:26-30
17. Shamsi FA, Lin K, Sady C, Nagaraj RH. Methylglyoxalderived modifications in lens aging and cataract formation. Invest Ophthalmol Vis Sci 1998; 39:2355-2364
18. Saxena P, Saxena AK, Cui X-L, et al. Transition metalcatalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Invest Ophthalmol Vis Sci 2000; 41:1473-1481